New Radiotherapy Treatment Technology

Shropshire has become the 18th location nationwide to adopt Surface Guided Radiotherapy (SGRT), a technology that removes the need for permanent tattoos in cancer treatment. SGRT has been installed in the Radiotherapy department of the Lingen Davies Cancer Centre at The Royal Shrewsbury Hospital, which treats up to 12,000 patients annually from Shropshire, Telford & Wrekin, and Mid Wales.

Key Benefits:

No Permanent Tattoos: SGRT eliminates the need for tattoos, which many patients find distressing.

Enhanced Patient Comfort: Reduces the discomfort of being physically moved into position by staff.

Increased Efficiency: Expected to reduce waiting times and increase service capacity.

The technology was funded by a £416,666 donation from The Directors of Telford Plaza Ltd to the Lingen Davies Cancer Fund. Naomi Atkin, CEO of Lingen Davies, emphasized the transformative impact SGRT will have on patient experiences, noting its limited availability in the UK.

The managing director of Telford Plaza Ltd highlighted the company’s commitment to community support through direct funding of tangible assets. Studies indicate that tattoos negatively affect up to 70% of breast cancer survivors, and 78% would prefer tattoo-free radiotherapy.

SGRT not only improves mental health and well-being but also reduces physical stress on both patients and staff, maintaining dignity and enhancing overall quality of life.

Previous Post
United School Experiences
Next Post
Benefits of Dry Needling in Physiotherapy
keyboard_arrow_up